Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
JSC “Latvijas Gāze”: Unaudited financial results of JSC “Latvijas Gāze” for 2023
-
UNILEVER RENEWS MULTI-YEAR NUMERATOR PARTNERSHIP TO DRIVE GROWTH
-
Form 8.3 - LondonMetric Property Plc
-
Alliance Trust PLC - Net Asset Value
-
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
-
Form 8.3 - LXI REIT PLC
-
Form 8.3 - [GCP Asset Backed Income Fund Ltd]
-
Form 8.3 - ABRDN European Logistics Income PLC
-
Telos Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
-
FuelCell Energy Announces First Quarter of Fiscal 2024 Results Conference Call on March 7, 2024 at 10 A.M. Eastern Time
-
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the
-
Deep Water Point & Associates Unveils Revolutionary Contract Vehicle Management Solution
-
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on
-
Leveraging Artificial Intelligence for Vision Applications and Technologies Market Expected to Reach $45 Billion By 2028
-
Form 8.3 - Young & Co's Brewery plc
-
Form 8.3 - Irish Residential Properties REIT plc
-
Music Licensing, Inc. Clears "Shell Risk" Designation from OTC Markets Group Profile
-
Music Licensing, Inc. Clears "Shell Risk" Designation from OTC Markets Group Profile
-
REE Announces Pricing of Public Offering of Ordinary Shares
-
Form 8.3 - Urban Logistics REIT plc
-
Vyre Live Announces Opening of Vyre Live Studios DTLA
-
Palomar Holdings, Inc. Appoints Thomas Bradley to its Board of Directors
-
Eagle Bulk Shipping Inc. Reports Results for the Fourth Quarter of 2023
-
Empowering the Future of Healthcare: How Healthcare Triangle's AI Initiative Sets a New Standard in Patient Care Excellence
-
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
-
Mass Technology Leadership Council Announces Tech Top 50
-
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
-
Discovery Lithium’s 2023 Exploration Program Sets the Stage for 2024
-
SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference
-
Chiesi Global Rare Diseases Launches “Rethink Acromegaly” Campaign to Provide Important Disease Education and Support to the Acromegaly Community
-
Splash Beverage Group Appoints Dr. John Paglia, a Professor of Finance at Pepperdine Graziadio Business School, to Its Board of Directors
-
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
-
Empowering the Future of Healthcare: How Healthcare Triangle's AI Initiative Sets a New Standard in Patient Care Excellence
-
People’s First Choice, LLC (“Blüm Santa Ana”) Granted Temporary Restraining Order Against New Patriot Holdings, Inc.
-
Workhorse Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Tuesday, March 12, 2024 at 12:00 p.m. ET
-
Comscore and TEGNA Sign Multi-Year Agreement for Local Linear and Cross-Platform Audience Measurement
-
Dyadic to Attend Industry Events in March
-
Form 8.3 - UK Commercial Property REIT
-
ProVen Growth and Income VCT plc: Total voting rights
-
ProVen VCT plc: Total voting rights
-
Alumis Presents Preclinical Data for Allosteric TYK2 Inhibitor A-005 at ACTRIMS
-
Euro Sun Mining Concludes Successful Meetings with Romanian Ministries and Issues Promissory Note
-
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Dat
-
Refined Metals Corp. Announces Planned Name Change to Refined Energy Corp.
-
PainReform Provides Year-End Business Update
-
Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference
-
Company Statement
-
Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
